Nucleolin-aptamer therapy in retinoblastoma: molecular changes and mass spectrometry-based imaging
Retinoblastoma (RB) is an intraocular childhood tumor which, if left untreated, leads to blindness and mortality. Nucleolin (NCL) protein which is differentially expressed on the tumor cell surface, binds ligands and regulates carcinogenesis and angiogenesis. We found that NCL is over expressed in R...
Guardado en:
Autores principales: | Nithya Subramanian (Autor), Amitava Srimany (Autor), Jagat R Kanwar (Autor), Rupinder K Kanwar (Autor), Balachandran Akilandeswari (Autor), Pukhraj Rishi (Autor), Vikas Khetan (Autor), Madavan Vasudevan (Autor), Thalappil Pradeep (Autor), Subramanian Krishnakumar (Autor) |
---|---|
Formato: | Libro |
Publicado: |
Elsevier,
2016-01-01T00:00:00Z.
|
Materias: | |
Acceso en línea: | Connect to this object online. |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Understanding the mechano and chemo response of retinoblastoma tumor cells
por: Gopal Divya, et al.
Publicado: (2022) -
Characterization and Molecular Mechanism of Peptide-Conjugated Gold Nanoparticle Inhibiting p53-HDM2 Interaction in Retinoblastoma
por: Sushma Kalmodia, et al.
Publicado: (2017) -
Nucleolin-Targeting AS1411 Aptamer-Conjugated Nanospheres for Targeted Treatment of Glioblastoma
por: Kyeongjin Seo, et al.
Publicado: (2024) -
Locking up the AS1411 Aptamer with a Flanking Duplex: Towards an Improved Nucleolin-Targeting
por: André Miranda, et al.
Publicado: (2021) -
Development of a novel PROTAC using the nucleic acid aptamer as a targeting ligand for tumor selective degradation of nucleolin
por: Lin Zhang, et al.
Publicado: (2022)